Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia-Reference-Cited by-同舟云学术

Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia

Published:2007-04-20 Issue:5 Volume:23 Page:1169-1176
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Kalogirou Mihalis¹,Tsimihodimos Vasilis¹,Gazi Irene¹,Filippatos Theodosios¹,Saougos Vasilis¹,Tselepis Alexandros D.²,Mikhailidis Dimitri P.³,Elisaf Moses¹

Affiliation:

1. Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece

2. Laboratory of Biochemistry, Department of Chemistry, University of Ioannina, Ioannina, Greece

3. Department of Clinical Biochemistry, Royal Free and University College Medical School, London, UK

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079907X188062

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Density Lipoprotein Subclasses and Their Role in the Prevention and Treatment of Cardiovascular Disease: A Narrative Review;International Journal of Molecular Sciences;2024-07-18

2. Efficacy and Safety of Bempedoic Acid in Patients with High Cardiovascular Risk: An Update;Current Vascular Pharmacology;2024-07

3. Targeting the vivid facets of apolipoproteins as a cardiovascular risk factor in rheumatoid arthritis;Canadian Journal of Physiology and Pharmacology;2024-05-01

4. Are We Using Ezetimibe As Much As We Should?;Biomarker Insights;2024-01

5. Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?;Metabolites;2023-01-18